EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 93 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $16,943 | +19.5% | 2,250 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $14,175 | -54.5% | 2,250 | -40.0% | 0.00% | 0.0% |
| Q1 2022 | $31,125 | +166.5% | 3,750 | +66.7% | 0.00% | – |
| Q4 2021 | $11,678 | -22.3% | 2,250 | 0.0% | 0.00% | -100.0% |
| Q3 2021 | $15,030 | -21.6% | 2,250 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $19,170 | -3.7% | 2,250 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $19,913 | -28.0% | 2,250 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $27,653 | +51.0% | 2,250 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $18,315 | +163.1% | 2,250 | +210.3% | 0.00% | – |
| Q2 2020 | $6,960 | +70.6% | 725 | +20.8% | 0.00% | – |
| Q1 2020 | $4,080 | -54.4% | 600 | 0.0% | 0.00% | -100.0% |
| Q4 2019 | $8,940 | +45.4% | 600 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $6,150 | +190.1% | 600 | +200.0% | 0.00% | – |
| Q2 2019 | $2,120 | -24.2% | 200 | 0.0% | 0.00% | – |
| Q1 2019 | $2,796 | +37.6% | 200 | 0.0% | 0.00% | – |
| Q4 2018 | $2,032 | -15.3% | 200 | 0.0% | 0.00% | – |
| Q3 2018 | $2,400 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Simplify Asset Management Inc. | 2,700,000 | $823,500 | 0.09% |
| 683 Capital Management, LLC | 2,650,000 | $808,250 | 0.06% |
| GSA CAPITAL PARTNERS LLP | 355,867 | $109 | 0.01% |
| RBF Capital, LLC | 391,265 | $119,336 | 0.01% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 393,975 | $120,162 | 0.00% |
| XTX Topco Ltd | 15,597 | $4,757 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 106,700 | $32,544 | 0.00% |
| AMERIPRISE FINANCIAL INC | 8,592,471 | $2,620,704 | 0.00% |
| DRW Securities, LLC | 120,365 | $37 | 0.00% |
| DFPG INVESTMENTS, LLC | 32,430 | $10,896 | 0.00% |